AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea
· Delayed Price · Currency is KRW 7,520.00
+150.00 (2.04%)
Apr 1, 2025, 3:30 PM KST
AptaBio Therapeutics Revenue
In the year 2024, AptaBio Therapeutics had annual revenue of 3.36B KRW with 937.76% growth. AptaBio Therapeutics had revenue of 744.01M in the quarter ending December 31, 2024, with 157.26% growth.
Revenue
3.36B
Revenue Growth
+937.76%
P/S Ratio
52.67
Revenue / Employee
n/a
Employees
32
Market Cap
202.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.36B | 3.04B | 937.76% |
| Dec 31, 2023 | 323.87M | 275.52M | 569.80% |
| Dec 31, 2022 | 48.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition